Cystic Fibrosis Lung
Rare Disease·MeSH: Cystic Fibrosis
Prevalence
4.0 / 100K
Incidence
3.5 / 100K/yr
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| 4D-710 | 4D Molecular Therapeutics, Inc. (FDMT) |
Frequently asked questions
How many drugs are in development for Cystic Fibrosis Lung?
BioSniper tracks 1 drug in development for Cystic Fibrosis Lung across 1 company.
How many clinical trials target Cystic Fibrosis Lung?
There are 1 clinical trial targeting Cystic Fibrosis Lung tracked by BioSniper.
What is the prevalence of Cystic Fibrosis Lung?
The estimated prevalence of Cystic Fibrosis Lung is approximately 4.0 per 100,000 population.
Deep-dive into Cystic Fibrosis Lung
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis